← Back to Search

Home Biofeedback Therapy for Bowel and Urinary Incontinence (Bioanatoner Trial)

N/A
Recruiting
Led By Satish Rao, MD, PhD
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with constipation and dyssynergic defecation must meet Rome IV criteria for functional constipation with specific symptoms
Patients with constipation and dyssynergic defecation must demonstrate a dyssynergic pattern of defecation during repeated attempts, as well as specific criteria on anorectal manometry
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks & 12 weeks
Awards & highlights

Bioanatoner Trial Summary

This trial tests a home biofeedback system to help people with constipation, urinary leakage, or stool leakage. It will compare it to standard care and look at its safety and cost-effectiveness.

Who is the study for?
This trial is for individuals with bowel or urinary incontinence, or bedwetting. Participants must have had symptoms for several months and meet specific diary criteria. Those with constipation need to fit the Rome IV criteria and show a certain pattern on tests. People can't join if they have related structural diseases, severe health conditions, are using opioids recently, or are pregnant/nursing.Check my eligibility
What is being tested?
The study is testing home biofeedback therapy using wireless devices and apps against office-based therapy to treat defecation issues and incontinence. It aims to see which method is more effective, safer, and cost-efficient by comparing patient outcomes from both treatments.See study design
What are the potential side effects?
While not explicitly stated here, biofeedback therapy generally has minimal side effects but may include discomfort during use of the equipment or minor psychological stress due to self-monitoring.

Bioanatoner Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I meet the specific criteria for functional constipation.
Select...
I have constipation due to muscle coordination issues, confirmed by a special test.

Bioanatoner Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks & 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks & 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The number of complete spontaneous bowel movements (CSBM) per week for patients with dyssynergic defecation
the number of Urinary Incontinence (UI) episodes for UI group
the number of fecal incontinence (FI) episodes for the FI group
Secondary outcome measures
Amplitudes (Millivolts of the nerve) for lumbo-rectal Motor Evoked Potential (MEP) for patients within all 3 groups
Amplitudes (Millivolts of the nerve) for sacro-rectal Motor Evoked Potential (MEP) for patients within all 3 groups
Anal Sphincter Function-Anal Resting Pressure for patients within all 3 groups
+29 more

Bioanatoner Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Home Biofeedback Therapy (HBT)Experimental Treatment1 Intervention
HBT for patients with constipation and dyssynergic defecation: HBT for patients with FI HBT for patients with UI All patients will be advised to practice HBT at least once or twice a day for six weeks.
Group II: Office Biofeedback Therapy (OBT)Active Control1 Intervention
OBT for patients with constipation and dyssynergic defecation. OBT for patients with FI. OBT for patients with UI. All patients will receive office biofeedback, once weekly, over six weeks.

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor
211 Previous Clinical Trials
84,996 Total Patients Enrolled
Satish Rao, MD, PhDPrincipal InvestigatorAugusta University
4 Previous Clinical Trials
121 Total Patients Enrolled

Media Library

Home Biofeedback therapy Clinical Trial Eligibility Overview. Trial Name: NCT05771597 — N/A
Urinary Incontinence Research Study Groups: Home Biofeedback Therapy (HBT), Office Biofeedback Therapy (OBT)
Urinary Incontinence Clinical Trial 2023: Home Biofeedback therapy Highlights & Side Effects. Trial Name: NCT05771597 — N/A
Home Biofeedback therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05771597 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the main objectives of this experiment?

"The primary metric of efficacy over the course of this 12-week trial will be evaluating the number of fecal incontinence (FI) episodes in patients with FI. Secondary outcomes include measuring stool consistence using Bristol Stool Scale, quantifying spontaneous bowel movements for those with dyssynergic defecation, and rating straining effort on a 1-3 scale for participants with dyssynergic defecation; higher scores indicating more severe strain."

Answered by AI

Are individuals able to participate in this clinical examination at the moment?

"This research is still open for recruitment, as indicated on clinicaltrials.gov. The first posting was made on March 27th 2023 and the information was last edited a mere 17 days later on April 14th."

Answered by AI

Could you provide an estimate of how many individuals are participating in this trial?

"Affirmative. The information available on clinicaltrials.gov explicitly states that this medical trial is presently recruiting individuals to join the study; initially posted in March of 2023 and last updated few weeks later, they are currently searching for 72 people from one site."

Answered by AI
~44 spots leftby Dec 2025